Literature DB >> 10981154

Review of recent Framingham study hypertension research.

W B Kannel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10981154     DOI： 10.1007/s11906-000-0004-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  7 in total

1.  Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.

Authors:  A Mosterd; R B D'Agostino; H Silbershatz; P A Sytkowski; W B Kannel; D E Grobbee; D Levy
Journal:  N Engl J Med       Date:  1999-04-22       Impact factor: 91.245

2.  Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

Authors:  S S Franklin; S A Khan; N D Wong; M G Larson; D Levy
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

3.  Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham heart study.

Authors:  J P Singh; M G Larson; T A Manolio; C J O'Donnell; M Lauer; J C Evans; D Levy
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

4.  Profile for estimating risk of heart failure.

Authors:  W B Kannel; R B D'Agostino; H Silbershatz; A J Belanger; P W Wilson; D Levy
Journal:  Arch Intern Med       Date:  1999-06-14

5.  Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  D M Lloyd-Jones; J C Evans; M G Larson; C J O'Donnell; D Levy
Journal:  Hypertension       Date:  1999-09       Impact factor: 10.190

6.  Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study.

Authors:  J P Singh; M G Larson; H Tsuji; J C Evans; C J O'Donnell; D Levy
Journal:  Hypertension       Date:  1998-08       Impact factor: 10.190

7.  Assessment of autonomic nervous activity by heart rate spectral analysis in patients with variant angina.

Authors:  H Yoshio; M Shimizu; N Sugihara; Y Kita; K Shimizu; F Minagawa; H Nakabayashi; R Takeda
Journal:  Am Heart J       Date:  1993-02       Impact factor: 4.749
  7 in total
  5 in total

1.  Consumption of hydrogen-rich water alleviates renal injury in spontaneous hypertensive rats.

Authors:  Hai-Guang Xin; Bei-Bei Zhang; Zhi-Qin Wu; Xiao-Feng Hang; Wen-Sheng Xu; Wu Ni; Rui-Qi Zhang; Xiao-Hui Miao
Journal:  Mol Cell Biochem       Date:  2014-03-21       Impact factor: 3.396

2.  On the replication of genetic associations: timing can be everything!

Authors:  Jessica Lasky-Su; Helen N Lyon; Valur Emilsson; Iris M Heid; Cliona Molony; Benjamin A Raby; Ross Lazarus; Barbara Klanderman; Manuel E Soto-Quiros; Lydiana Avila; Edwin K Silverman; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Florian Kronenberg; Caren Vollmert; Thomas Illig; Caroline S Fox; Daniel Levy; Nan Laird; Xiao Ding; Matt B McQueen; Johannah Butler; Kristin Ardlie; Constantina Papoutsakis; George Dedoussis; Christopher J O'Donnell; H-Erich Wichmann; Juan C Celedón; Eric Schadt; Joel Hirschhorn; Scott T Weiss; Kari Stefansson; Christoph Lange
Journal:  Am J Hum Genet       Date:  2008-04       Impact factor: 11.025

3.  Contribution of mitochondrial function to exercise-induced attenuation of renal dysfunction in spontaneously hypertensive rats.

Authors:  Qi Gu; Li Zhao; Yan-Ping Ma; Jian-Dong Liu
Journal:  Mol Cell Biochem       Date:  2015-05-12       Impact factor: 3.396

4.  Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR.

Authors:  Carrie M Elks; Nithya Mariappan; Masudul Haque; Anuradha Guggilam; Dewan S A Majid; Joseph Francis
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-10

5.  Captopril alleviates hypertension-induced renal damage, inflammation, and NF-κB activation.

Authors:  Zhongyuan Gan; Dan Huang; Jiaye Jiang; Yuan Li; Hanqing Li; Yan Ke
Journal:  Braz J Med Biol Res       Date:  2018-09-03       Impact factor: 2.590
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.